Top Markets
Coin of the day
Climb Bio, Inc. Climb Bio, Inc.

Climb Bio, Inc.

CLYM
Classement en actions #10440
Climb Bio, Inc. is a biopharmaceutical firm dedicated to crafting therapeutic... Climb Bio, Inc. is a biopharmaceutical firm dedicated to crafting therapeutic solutions for inflammatory diseases driven by autoimmune responses. Its primary investigational asset is budoprutug, an anti-CD19 monoclonal antibody. This treatment is being advanced for a range of autoimmune conditions, including systemic lupus erythematosus, lupus nephritis, immune thrombocytopenia, and membranous nephropathy. The entity, established in 2018, officially rebranded as Climb Bio, Inc. in October 2024, having previously operated under the name Eliem Therapeutics, Inc. Its corporate headquarters are situated in Wilmington, Delaware.
Prix de l'action
$14.66
Dernière synchronisation: 2026-08-28
Capitalisation boursière
$839.37M
Changement (1 jour)
-2.67%
Changement (1 an)
557.32%
Pays
US
Échange Climb Bio, Inc. (CLYM)

Catégorie

Historique des divisions d’actions pour Climb Bio, Inc. (CLYM)
L’action Climb Bio, Inc. (symbole : CLYM) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 30, 2026.
Une action CLYM achetée avant le Aug 30, 2026 équivaudrait aujourd’hui à 0 actions CLYM.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH